Good news if you're a Sabril enthusiast!
You have until December 23rd to share your written opinion regarding the pending FDA review of Sabril (aka. Vigabatrin) to be used in the treatment of Infantile Spasms.
Click here if you'd like to get your advocate groove on too!
No comments:
Post a Comment